Wellcome, a global charitable foundation dedicated to improving health and advancing science, has announced the addition of two key leaders to its executive team. Dr. Jimmy Volmink has been appointed as Chief Equity, Diversity and Inclusion Officer, and Dr. Beth Thompson will assume the role of Chief Strategy Officer. These appointments reflect Wellcome's commitment to fostering equity, promoting diversity and inclusion, and driving strategic impact in the fields of health and science.
Dr. Jimmy Volmink, a renowned figure in global health, will join Wellcome in October as the organization's first Chief Equity, Diversity and Inclusion Officer. Dr. Volmink brings a wealth of experience to the role, having previously served as the Dean of Medicine and Health Sciences at Stellenbosch University in South Africa. With a background in medicine and public health, he has dedicated his career to addressing health disparities and advancing evidence-based healthcare.
During his tenure at Stellenbosch University, Dr. Volmink spearheaded significant initiatives, including the establishment of a department of global health and the promotion of diversity within the institution. As Chief Equity, Diversity and Inclusion Officer, he will lead Wellcome's efforts to become an inclusive funder and promote inclusivity across all aspects of the organization's work. Dr. Volmink believes that embracing a broader spectrum of lived experiences and perspectives in research can mitigate bias and unlock the full potential of science in addressing global health challenges.
Dr. Beth Thompson, who has been with Wellcome since 2009, has been appointed as Chief Strategy Officer. Throughout her tenure, Dr. Thompson has played a pivotal role in leading policy and advocacy initiatives in various areas, including pandemic preparedness financing and clinical trials regulation. She has held several key positions within Wellcome, including Head of UK and EU Policy and Advocacy, as well as Associate Director for Policy.
As Chief Strategy Officer, Dr. Thompson will oversee Wellcome's policy, government relations, and strategic partnerships teams. She will also be responsible for the organization's program management function, ensuring the effective delivery of Wellcome's mission and managing major internal projects. Dr. Thompson's expertise in policy development and her track record in fostering collaborations will be instrumental in driving impactful change and furthering Wellcome's support for scientific advancements.
These strategic appointments highlight Wellcome's dedication to championing equity, diversity, and inclusion in the fields of health and science. With Dr. Jimmy Volmink leading efforts to foster inclusivity and Dr. Beth Thompson driving strategic initiatives, Wellcome is poised to make significant contributions toward advancing global health and scientific discovery.
Click here to read the original press release.
